In: 

Rapid Risk Assessment - European Centre for Disease Prevention and Control

Conclusions and options for response

European Union/European Economic Area (EU/EEA) Member States should consider a range of mitigation
measures regarding the Zika virus epidemic due to:

- the current circulation of Zika virus on several continents
- the evidence of an association between Zika virus infection during pregnancy and congenital
malformations of the central nervous system (CNS)
- the association between Zika virus infection and Guillain–Barré syndrome (GBS)
- the risk of local vector-borne transmission in Europe in areas where potential vectors are still active (e.g. Madeira) during the 2016 autumn season; in the continental EU, the risk of local vector-borne transmission will decrease in the coming months because the season for Zika virus transmission by vectors will become unfavourable
- the possibility of sexual transmission from returning travellers
- the risk of Zika virus transmission via substances of human origin (SoHO).
The options for risk reduction and the definitions below are based on the current evidence, which take into
account current uncertainties. These are subject to change as new evidence emerges.

Download full publication: